Facebook
Twitter
Telegram
Report an ErrorPieris Pharmaceuticals Financial Statements 2011-2024 | PIRS
Annual Financial Statements Pieris Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
16.2 M | 91.2 M | 244 M | 138 M | 185 M | 141 M | 335 M | 88 M | 59.5 M | 38.8 M | - | - | - |
Shares |
90.1 M | 74.2 M | 64.5 M | 54.3 M | 50.6 M | 53.1 M | 43.9 M | 41.7 M | 34.4 M | 13.9 M | - | - | - |
Historical Prices |
0.18 | 1.23 | 3.78 | 2.5 | 3.62 | 2.66 | 7.55 | 1.41 | 2.29 | - | - | - | - |
Net Income |
-24.5 M | -33.3 M | -45.7 M | -37.2 M | -25.5 M | -26.8 M | -17.6 M | -22.8 M | -14.1 M | -15.7 K | -274 | - | - |
Revenue |
42.8 M | 25.9 M | 31.4 M | 29.3 M | 46.3 M | 29.1 M | 25.3 M | 5.83 M | 2.93 M | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 29.3 M | - | - | - | - | 2.93 M | - | - | - | - |
Operating Income |
-29.8 M | -43.5 M | -51.8 M | -33.9 M | -27.2 M | -30.8 M | -14.6 M | -22.8 M | -13.7 M | -7.2 M | 554 K | - | - |
Interest Expense |
-250 K | 1.3 M | 2.4 M | -3.66 M | -26 K | 1.8 M | -2.1 M | 120 K | 10.9 K | 2.65 M | 494 K | - | - |
EBITDA |
-27.9 M | -40.7 M | -49.4 M | -31.6 M | -26.1 M | -30.3 M | -14.2 M | -22.4 M | -13.4 M | -15.7 K | -274 | - | - |
Operating Expenses |
72.6 M | 69.4 M | 83.2 M | 63.2 M | 73.4 M | 59.9 M | 39.9 M | 28.6 M | 16.6 M | 15.7 K | - | - | - |
General and Administrative Expenses |
16.9 M | 16.4 M | 16.6 M | 16.7 M | 18.4 M | 18.4 M | 17.6 M | 8.89 M | 8.37 M | 15.2 K | 274 | - | - |
All numbers in USD currency
Quarterly Income Statement Pieris Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
1.24 M | 1.24 M | 98.9 M | 98.9 M | 931 K | 74.5 M | 74.4 M | 74.1 M | 73.7 M | 72.2 M | 67.7 M | 61.9 M | 56.3 M | 56 M | 54.3 M | 52.4 M | 55.2 M | 55.2 M | 49.4 M | 49.2 M | 50.9 M | 54.2 M | 54.1 M | 54 M | 50 M | 45 M | 44.4 M | 43.4 M | 43.1 M | 43.1 M | 43.1 M | 40.9 M | 39.8 M | 39.8 M | 38.9 M | 29.4 M | 29.3 M | 29.3 M | 6.25 M | 11.8 M | 5 M | 5 M | 6.1 M | 5 M | - | - | - | - | - | - | - | - | - |
Net Income |
-4.89 M | - | -10.8 M | 3.98 M | -13.2 M | - | -9.74 M | -10.3 M | -5.1 M | - | -16.5 M | -15.5 M | -4.17 M | - | -14.3 M | -4.95 M | -3.6 M | - | -2.59 M | -11.8 M | -10.3 M | - | -6.15 M | -203 K | -8.71 M | - | -7.06 M | -10.1 M | -7.99 M | - | -6.2 M | -5.88 M | -4.16 M | - | -3.92 M | -3.53 M | -3.7 M | - | -2.02 M | -2.88 M | -13.9 K | -2.2 K | -5.76 K | -7.96 K | - | - | - | - | - | - | - | - | - |
Revenue |
53 K | - | 19.5 M | 20.1 M | 1.94 M | - | 5.37 M | 3.7 M | 11 M | - | 4.06 M | 3.28 M | 15.6 M | - | 2.94 M | 11.2 M | 13.3 M | - | 15.1 M | 5.33 M | 8.54 M | - | 8.34 M | 11.7 M | 4.15 M | - | 3.93 M | 1.85 M | 1.34 M | - | 785 K | 1.07 M | 1.25 M | - | 415 K | 160 K | 218 K | - | 18.7 K | 698 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-5.3 M | - | -11.8 M | 2.06 M | -15.5 M | - | -12.2 M | -12.3 M | -7.46 M | - | -19 M | -16.8 M | -5.06 M | - | -13 M | -4.66 M | -3.86 M | - | -2.91 M | -12.2 M | -10.7 M | - | -7.8 M | -2.24 M | -8.14 M | - | -5.18 M | -7.89 M | -8.01 M | - | -6.18 M | -5.8 M | -4.38 M | - | -3.88 M | -3.53 M | -3.7 M | - | -1.84 M | -2.77 M | -13.9 K | -2.2 K | -5.76 K | -7.96 K | - | - | - | - | - | - | - | - | - |
Interest Expense |
171 K | - | 506 K | -161 K | -57 K | - | 723 K | 676 K | 229 K | - | 678 K | 464 K | 884 K | - | -1.34 M | -424 K | -60 K | - | -55 K | 23 K | -171 K | - | 1.15 M | 1.23 M | -903 K | - | -1.73 M | -1.38 M | 12 K | - | -18.2 K | -87.8 K | 220 K | - | -1.93 K | 53 | 4.17 K | - | 148 | 114 K | 109 K | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-5.33 M | - | - | - | -14.9 M | - | -9.97 M | -12.3 M | -7.46 M | - | -17.2 M | -16.8 M | -5.06 M | - | -13 M | -4.66 M | -3.52 M | - | -2.55 M | -12 M | -10.5 M | - | -7.4 M | -1.97 M | -8 M | - | -4.92 M | -7.68 M | -7.91 M | - | -6 M | -5.71 M | -4.29 M | - | -3.65 M | -3.38 M | -3.62 M | - | -1.56 M | -2.58 M | 81.6 K | -2.2 K | -5.76 K | -7.96 K | - | - | - | - | - | - | - | - | - |
Operating Expenses |
5.36 M | - | 31.3 M | 18 M | 17.4 M | - | 17.5 M | 16 M | 18.4 M | - | 23.1 M | 20 M | 20.7 M | - | 15.9 M | 15.9 M | 17.1 M | - | 18 M | 17.6 M | 19.2 M | - | 16.1 M | 13.9 M | 12.3 M | - | 9.11 M | 9.74 M | 9.35 M | - | 6.96 M | 6.87 M | 5.63 M | - | 4.29 M | 3.69 M | 3.92 M | - | 1.86 M | - | 13.9 K | 2.2 K | 5.76 K | 7.96 K | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
4.14 M | - | 6.84 M | 3.66 M | 4.02 M | - | 3.95 M | 4.08 M | 4.38 M | - | 4.13 M | 4.25 M | 4.13 M | - | 4.12 M | 4.57 M | 4.36 M | - | 4.84 M | 4.19 M | 4.93 M | - | 4.75 M | 4.78 M | 4.35 M | - | 2.85 M | 4.35 M | 3.99 M | - | 2.34 M | 2.37 M | 1.97 M | - | 2.24 M | 1.97 M | 2.39 M | - | 933 K | 2.35 M | 18 | - | 12 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency